Search Results 351-360 of 15176 for IUD

1. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   An effective form of contraception is defined as using hormonal contraceptives or an intrauterine device combined with at least 1 of the following forms of ...

2. A Study of the Efficacy of Lorcaserin for Weight Loss in Overweight Peri- and Postmenopausal Women - Mayo Clinic

   Copper IUD; Hysterectomy and/or bilateral salpingo-oophorectomy; Tubal ligation; Abstinence (no sex). Any current (past 4 weeks) or planned use of. Estrogen ...

3. Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients - Mayo Clinic

   Includes, but is not limited to, barrier with additional spermicidal foam or jelly, intrauterine device, hormonal contraception (started at least 30 days ...

4. Study Comparing NOVOCART 3D and Microfracture Surgery for Treatment of Articular Knee Cartilage - Mayo Clinic

   ... IUD, intra-muscular contraceptive). Clinically significant rheumatological disease (including Lyme, Fibromyalgia) . Clinically significant arthritis ...

5. Getting pregnant Fertility - Mayo Clinic

   From Mayo Clinic to your inbox. Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing ...

6. Colposcopy - Mayo Clinic

   Find out why colposcopy is done and what to expect during an exam to diagnose cancer and other problems affecting the cervix, vagina and vulva.

7. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

   Intrauterine device (IUD);; Hormonal (birth control pill, injections, implants);; Bilateral tubal ligation;; Successful vasectomy;; Male condom (additional ...

8. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

   Intrauterine device (IUD); Intrauterine hormone-releasing system (IUS); Bilateral tubal occlusion; Vasectomized partner; Sexual abstinence. Birth control ...

9. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   Intrauterine device (IUD);; Intrauterine hormonal-releasing system (IUS);; Bilateral tubal ligation/occlusion;; Vasectomized partner (provided that partner is ...

10. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic

    ... intrauterine device) will be considered eligible if they had a minimum of 4 menstrual cycles within the last six months prior to starting on the contraceptive.